Direct-to-Consumer Expansion CV Sciences recently launched PlusHLTH.com as a dedicated direct-to-consumer channel for its +PlusHLTH product line, signaling a shift toward owned retail and higher customer acquisition control. This presents a sales opportunity to partner on exclusive SKUs, white-label opportunities, or co-marketing initiatives with retailers seeking differentiated wellness offerings.

New Product Ventures The company has ongoing product development including EMPOWR plant-based protein with creatine and Aura Collection THC Fizz Tablets, indicating a breadth of consumer wellness formats. Sales teams can target gyms, fitness brands, and supplement distributors with bundle deals, cross-sell of protein formats, and seasonal promotions around wellness trends.

Cannabinoid and Non-Cannabinoid Lines CV Sciences operates both cannabinoid-based products and cannabinoid-free lines under +PlusHLTH, enabling cross-sell strategies across different customer segments. This dual approach offers opportunities to diversify distributor portfolios and collaborate with retailers targeting diverse regulatory environments and consumer preferences.

Acquisition Momentum The 2024 acquisition of Extract Labs indicates strategic consolidation to expand product breadth and market reach. This could open integration opportunities for wholesale distributors, private-label manufacturers, and co-branding ventures that leverage combined R&D, supply chains, and customer bases.

Growth and Outreach Signals Revenue scale in the mid-range and active expansion into new product lines and D2C channels suggest a growing brand with increasing demand in wellness and science-backed products. This presents opportunities for channel partnerships, enterprise deals with wellness platforms, and inclusion in multi-brand storefronts to accelerate distribution.